Stock Updates

Today’s Top Gainers in the Market Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Healthcare

Today’s top gainers include the company Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) which is in the industry Biotechnology, gaining 0.33% today. In the last week its performance is -1.05%, and 4.44% for the past quarter. Currently, Vertex Pharmaceuticals Incorporated, VRTX has a target price of 110.11, so today’s gain of 0.33% is a significant step towards its target price. The GAP today is therefore 1.10%.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), has a market cap of 22921.3, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 97.90%.

At the current price of 92.12, it has a dividend yield of *TBA, and its target price is 110.11. This is with a profit margin of -17.70%, and total debt/equity of 0.84. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has a P/E of *TBA, as well as a forward P/E of 30.88.

With a current EPS of -1.13, and a forecasted EPS growth for next year at 197.70%,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has had a EPS growth for the past five years at 9.30%. For the next five years EPS growth is projected to be 53.30%.

Performance for the year is -17.65%. Since its IPO date on 7/24/1991, the total performance to date is -26.79%.

Volume today for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), is 1190797, while its average volume is 1353.08. Whilst the total gain today was 0.33%, it did have a day high of -11.19%.

Volatility for this week has been at 2.99%, and 3.62% for the month. The 52-week low for Vertex Pharmaceuticals Incorporated, VRTX has been 21.37%, while the 52-week-high has reached -31.62%.

Looking at its return of investments, which is -28.20%, and its return on assets is -11.00%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has an operating margin of -8.70%. With a sales growth of 159.80% quarter over quarter. Bearing in mind that Vertex Pharmaceuticals Incorporated, VRTX is in the sector Healthcare, its long-term debt/equity is 0.59, and has a current ratio of 2.3 and 2.2 for quick ratio.

So what is the value of Vertex Pharmaceuticals Incorporated? Well its PEG is *TBA, and the P/S is 14.72, along with a P/B of 22.97. Meanwhile it has a p/cash of 21.39.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment